J. Michael Schmidt

researcher

J. Michael Schmidt is …
instance of (P31):
humanQ5

External links are
P3835Mendeley person IDmichael-schmidt38
P496ORCID iD0000-0001-8141-2944

P734family nameSchmidtQ15240355
P735given nameJ.Q19803507
J.Q19803507
P106occupationresearcherQ1650915
P21sex or gendermaleQ6581097

Reverse relations

author (P50)
Q48168403Acute cerebral microbleeds in refractory status epilepticus
Q48837195Acute effects of intraventricular nicardipine on cerebral hemodynamics: A preliminary finding
Q48702013Acute effects of nimodipine on cerebral vasculature and brain metabolism in high grade subarachnoid hemorrhage patients
Q43103440Anemia is associated with metabolic distress and brain tissue hypoxia after subarachnoid hemorrhage.
Q40785141Assessment of Noninvasive Regional Brain Oximetry in Posterior Reversible Encephalopathy Syndrome and Reversible Cerebral Vasoconstriction Syndrome
Q48665847Brain injury visible on early MRI after subarachnoid hemorrhage might predict neurological impairment and functional outcome
Q83499143Can quantitative EEG reliably predict deterioration from delayed cerebral ischemia secondary to vasospasm?
Q34018874Cardiac arrhythmias after subarachnoid hemorrhage: risk factors and impact on outcome
Q46273306Cardiac output augmentation with fluid resuscitation improves brain tissue oxygenation after severe brain injury
Q36001623Causal Structure of Brain Physiology after Brain Injury from Subarachnoid Hemorrhage
Q80686406Cerebral infarction associated with acute subarachnoid hemorrhage
Q33697166Cerebral inflammatory response and predictors of admission clinical grade after aneurysmal subarachnoid hemorrhage
Q43487107Cerebral microbleeds in patients with acute subarachnoid hemorrhage
Q34951946Cerebral perfusion pressure thresholds for brain tissue hypoxia and metabolic crisis after poor-grade subarachnoid hemorrhage
Q48239041Cerebrovascular carbon dioxide reactivity and delayed cerebral ischemia after subarachnoid hemorrhage
Q82373157Cerebrovascular reactivity and vasospasm after subarachnoid hemorrhage: a pilot study
Q82297039Clinical response to hypertensive hypervolemic therapy and outcome after subarachnoid hemorrhage
Q82691642Clinical utility of brain tissue oxygen tension in treatment of brain injury more complicated than it appears
Q30924720Data collection and interpretation.
Q39880670Defining vasospasm after subarachnoid hemorrhage: what is the most clinically relevant definition?
Q36637976Early neurological deterioration after subarachnoid haemorrhage: risk factors and impact on outcome
Q37795389Effect of mannitol on brain metabolism and tissue oxygenation in severe haemorrhagic stroke
Q46275163Effect of packed red blood cell transfusion on cerebral oxygenation and metabolism after subarachnoid hemorrhage
Q36304075Effect of rebleeding on the course and incidence of vasospasm after subarachnoid hemorrhage
Q38051271Effectiveness and safety of nicardipine and labetalol infusion for blood pressure management in patients with intracerebral and subarachnoid hemorrhage.
Q36902791Effects of the neurological wake-up test on clinical examination, intracranial pressure, brain metabolism and brain tissue oxygenation in severely brain-injured patients
Q55346115Electrographic seizures after subarachnoid hemorrhage lead to derangement of brain homeostasis in humans.
Q46286323Ethnic disparities in end-of-life care after subarachnoid hemorrhage
Q48134598External ventricular drainage response in poor grade aneurysmal subarachnoid hemorrhage: effect on preoperative grading and prognosis
Q48966999Fluid responsiveness and brain tissue oxygen augmentation after subarachnoid hemorrhage
Q34344828Free Fatty acids and delayed cerebral ischemia after subarachnoid hemorrhage
Q82736409Frequency and clinical impact of asymptomatic cerebral infarction due to vasospasm after subarachnoid hemorrhage
Q51475637Global cerebral edema and brain metabolism after subarachnoid hemorrhage
Q82769038High-dose intra-arterial verapamil for the treatment of cerebral vasospasm after subarachnoid hemorrhage: prolonged effects on hemodynamic parameters and brain metabolism
Q37593258High-dose midazolam infusion for refractory status epilepticus
Q48769090Hyperoxia may be related to delayed cerebral ischemia and poor outcome after subarachnoid haemorrhage
Q40484529Impact of medical complications on outcome after subarachnoid hemorrhage
Q51713381Impact of nosocomial infectious complications after subarachnoid hemorrhage
Q46018920Impact of premorbid hypertension on haemorrhage severity and aneurysm rebleeding risk after subarachnoid haemorrhage.
Q46308100Impact of tight glycemic control on cerebral glucose metabolism after severe brain injury: a microdialysis study
Q35106607Inflammation, negative nitrogen balance, and outcome after aneurysmal subarachnoid hemorrhage
Q45363415Intracerebral monitoring of silent infarcts after subarachnoid hemorrhage
Q48116063Intracortical EEG for the detection of vasospasm in patients with poor-grade subarachnoid hemorrhage
Q43520407Intracortical electroencephalography in acute brain injury
Q37682677Intracranial multimodal monitoring for acute brain injury: a single institution review of current practices
Q35154916Intraventricular hemorrhage expansion in patients with spontaneous intracerebral hemorrhage
Q33892365Is pentobarbital safe and efficacious in the treatment of super-refractory status epilepticus: a cohort study.
Q37800041Left ventricular dysfunction and cerebral infarction from vasospasm after subarachnoid hemorrhage
Q53221207Long-term domain-specific improvement following poor grade aneurysmal subarachnoid hemorrhage
Q40329103Loss of Consciousness at Onset of Subarachnoid Hemorrhage as an Important Marker of Early Brain Injury.
Q92522004Medical Treatment Failure for Symptomatic Vasospasm After Subarachnoid Hemorrhage Threatens Long-Term Outcome
Q48650654Metabolic benefits of surface counter warming during therapeutic temperature modulation
Q40407087Metabolic impact of shivering during therapeutic temperature modulation: the Bedside Shivering Assessment Scale
Q81560046Monocyte chemoattractant protein-1 predicts outcome and vasospasm following aneurysmal subarachnoid hemorrhage
Q35449746Multimodality monitoring for cerebral perfusion pressure optimization in comatose patients with intracerebral hemorrhage
Q36953769Multimodality monitoring in neurocritical care
Q35246499Multimodality monitoring: informatics, integration data display and analysis
Q30544942Nonconvulsive seizures after subarachnoid hemorrhage: Multimodal detection and outcomes
Q33856333Nonconvulsive seizures in subarachnoid hemorrhage link inflammation and outcome
Q36093519Nutritional support and brain tissue glucose metabolism in poor-grade SAH: a retrospective observational study.
Q36376183Patient-Powered Reporting of Modified Rankin Scale Outcomes Via the Internet.
Q35758678Pearls & Oysters: the effects of renal replacement therapy on cerebral autoregulation
Q82600888Predicting long-term outcome in poor grade aneurysmal subarachnoid haemorrhage patients utilising the Glasgow Coma Scale
Q53530587Prediction of symptomatic vasospasm after subarachnoid hemorrhage: the modified fisher scale
Q40373407Predictors of global cognitive impairment 1 year after subarachnoid hemorrhage
Q39885928Predictors of long-term shunt-dependent hydrocephalus after aneurysmal subarachnoid hemorrhage. Clinical article.
Q42597555Preoperative prediction of long-term outcome in poor-grade aneurysmal subarachnoid hemorrhage
Q40338227Prevention of shivering during therapeutic temperature modulation: the Columbia anti-shivering protocol.
Q93258204Prognostic Significance of Sentinel Headache Preceding Aneurysmal Subarachnoid Hemorrhage
Q35623045Prolonged elevated heart rate is a risk factor for adverse cardiac events and poor outcome after subarachnoid hemorrhage
Q50995112Quantitative analysis of hemorrhage clearance and delayed cerebral ischemia after subarachnoid hemorrhage
Q48524255Quantitative analysis of hemorrhage volume for predicting delayed cerebral ischemia after subarachnoid hemorrhage
Q36297701Real time estimation of brain water content in comatose patients
Q48964653Reduced brain/serum glucose ratios predict cerebral metabolic distress and mortality after severe brain injury
Q49047694Relationship between C-reactive protein, systemic oxygen consumption, and delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage
Q46001653Renal dysfunction as an independent predictor of outcome after aneurysmal subarachnoid hemorrhage: a single-center cohort study.
Q37400544Resuscitation and critical care of poor-grade subarachnoid hemorrhage
Q40243528Risk factors for catheter-associated urinary tract infections in critically ill patients with subarachnoid hemorrhage
Q30703796Seizure burden in subarachnoid hemorrhage associated with functional and cognitive outcome
Q45747805Serum glucose variability and brain-serum glucose ratio predict metabolic distress and mortality after severe brain injury
Q48386518Spontaneous hyperventilation and brain tissue hypoxia in patients with severe brain injury
Q48851697Status epilepticus-induced hyperemia and brain tissue hypoxia after cardiac arrest
Q36015756Subarachnoid hemorrhage: who dies, and why?
Q33752318Systemic glucose variability predicts cerebral metabolic distress and mortality after subarachnoid hemorrhage: a retrospective observational study
Q34949499Tonic-clonic activity at subarachnoid hemorrhage onset: impact on complications and outcome
Q48510644Transcranial Doppler for predicting delayed cerebral ischemia after subarachnoid hemorrhage.
Q48647125Transcranial Doppler ultrasound in the acute phase of aneurysmal subarachnoid hemorrhage
Q85200231Transdermal nicotine replacement therapy in cigarette smokers with acute subarachnoid hemorrhage
Q39731872Ultra-early angiographic vasospasm associated with delayed cerebral ischemia and infarction following aneurysmal subarachnoid hemorrhage.